CD14 and Alzheimer disease: In addition, comparing NMOSD patients, in CD14+ monocytes from three MOG-AD patients, MALAT1 expression was reduced and miR-30b-5p expression was elevated, while BAFF mRNA overexpression was not significant (P = 0.7459, Figure S2).